What is the current valuation of the China fertility services market?

The market valuation was $3750.0 Million in 2024. Read More

What is the projected market size for the China fertility services market by 2035?

The market is expected to reach $12000.0 Million by 2035. Read More

What is the expected CAGR for the China fertility services market during the forecast period 2025 - 2035?

The expected CAGR is 11.15% during the forecast period. Read More

Which treatment type generated the highest revenue in the China fertility services market?

In Vitro Fertilization generated $1500.0 Million in 2024, indicating strong demand. Read More

What are the revenue projections for Intracytoplasmic Sperm Injection by 2035?

Revenue for Intracytoplasmic Sperm Injection is projected to reach $2800.0 Million by 2035. Read More

How does the revenue for fertility clinics compare to hospitals in 2024?

Fertility clinics generated $1125.0 Million, while hospitals generated $1875.0 Million in 2024. Read More

What segment of patient type is expected to see the most growth by 2035?

Female Infertility is projected to grow to $2400.0 Million by 2035. Read More

Which key players are leading the China fertility services market?

Key players include IVF Australia, CCRM Fertility, and Fertility Centers of Illinois. Read More

What is the revenue forecast for treatment services by 2035?

Treatment services are expected to reach $8400.0 Million by 2035. Read More

What is the projected revenue for same-sex couples seeking fertility services by 2035?

Revenue for same-sex couples is projected to reach $900.0 Million by 2035. Read More

China Fertility Services Market

ID: MRFR/HC/5690-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

China Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs) -Forecast to 2035

China Fertility Services Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Treatment Type (USD Million) | |
  1. 4.1.1 In Vitro Fertilization | |
  2. 4.1.2 Intracytoplasmic Sperm Injection | |
  3. 4.1.3 Artificial Insemination | |
  4. 4.1.4 Donor Egg | |
  5. 4.1.5 Surrogacy |
2. 4.2 Healthcare, BY Patient Type (USD Million) | |
  1. 4.2.1 Female Infertility | |
  2. 4.2.2 Male Infertility | |
  3. 4.2.3 Couples with Unexplained Infertility | |
  4. 4.2.4 Same-Sex Couples | |
  5. 4.2.5 Single Parents |
3. 4.3 Healthcare, BY End User (USD Million) | |
  1. 4.3.1 Fertility Clinics | |
  2. 4.3.2 Hospitals | |
  3. 4.3.3 Home Care |
4. 4.4 Healthcare, BY Service Type (USD Million) | |
  1. 4.4.1 Consultation Services | |
  2. 4.4.2 Diagnostic Services | |
  3. 4.4.3 Treatment Services 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 IVF Australia (AU) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Fertility Centers of Illinois (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 CCRM Fertility (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 New Hope Fertility Center (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Reproductive Health Specialists (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Clinica de Fertilidad (ES) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Fertility Associates (NZ) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Bourn Hall Clinic (GB) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 IVF Spain (ES) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 CHINA MARKET ANALYSIS BY TREATMENT TYPE |
6. 6.3 CHINA MARKET ANALYSIS BY PATIENT TYPE |
7. 6.4 CHINA MARKET ANALYSIS BY END USER |
8. 6.5 CHINA MARKET ANALYSIS BY SERVICE TYPE |
9. 6.6 KEY BUYING CRITERIA OF HEALTHCARE |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF HEALTHCARE |
12. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
14. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE |
15. 6.12 HEALTHCARE, BY TREATMENT TYPE, 2024 (% SHARE) |
16. 6.13 HEALTHCARE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million) |
17. 6.14 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE) |
18. 6.15 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Million) |
19. 6.16 HEALTHCARE, BY END USER, 2024 (% SHARE) |
20. 6.17 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
21. 6.18 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE) |
22. 6.19 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY PATIENT TYPE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Million) | |
  4. 7.2.4 BY SERVICE TYPE, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

China Healthcare Market Segmentation

Healthcare By Treatment Type (USD Million, 2025-2035)

In Vitro Fertilization
Intracytoplasmic Sperm Injection
Artificial Insemination
Donor Egg
Surrogacy

Healthcare By Patient Type (USD Million, 2025-2035)

Female Infertility
Male Infertility
Couples with Unexplained Infertility
Same-Sex Couples
Single Parents

Healthcare By End User (USD Million, 2025-2035)

Fertility Clinics
Hospitals
Home Care

Healthcare By Service Type (USD Million, 2025-2035)

Consultation Services
Diagnostic Services
Treatment Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓